Actively Recruiting
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Led by Assiut University · Updated on 2024-12-17
76
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Behçet's disease (BD) is a multi-system auto inflammatory disorder with vasculitic features. The exact etiological of BD is still obscure, although environmental and genetics factors have been found to be involved in disease pathogenesis.FSTL-1 can act as diagnostic and prognostic biomarkers for Some inflammatory autoimmune diseases including BD.
CONDITIONS
Official Title
Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Activity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult BD patients who fulfill the diagnosis criteria by the International Team for the Revision of the International Criteria for Behcet's Disease
You will not qualify if you...
- Individuals with other autoimmune diseases such as rheumatoid arthritis, dermatomyositis, scleroderma, or mixed connective tissue disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut University Hospitals
Asyut, Egypt, 71111
Actively Recruiting
Research Team
S
Sara Farrag, Lecturer
CONTACT
E
Eman Mohamed, Lecturer
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here